| Wissenschaftl. Titel | A phase II, randomized, active-controlled, multi-center study comparing the efficacy and safety of targeted therapy or cancer immunotherapy guided by genomic profiling versus platinum-based chemotherapy in patients with cancer of unknown primary site who have recieved three cycles of platinum doublet chemotherapy |
| Erkrankung |
Thorax:
Nicht-kleinzelliges Lungenkarzinom:
Erstlinie
CUP: Cancer of unknown primary: Erstlinie |
| Kurzprotokoll | Kurzprotokoll |
| Links | Weiterführende Informationen (HD) Weiterführende Informationen (NIH) Weiterführende Informationen (EudraCT) Weiterführende Informationen (M) |
erstellt 19.07.2019 Data entry X CCP
geändert 11.07.2023 Data entry II CCP